https://clinicaltrials.gov/ct2/show/NCT03670953?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F02%2F2019&lupd_d=14&sort=nwst
STUDY TITLE:
A Study to Evaluate the Safety and Efficacy of IPX203 in Parkinson’s Disease Patients With Motor Fluctuations
DESCRIPTION:
Condition: Parkinson’s Disease (Disorder)
Interventions: Drug: IR CD-LD; Drug: IPX203 ER CD-LD; Other: IPX203 placebo; Other: IR CD-LD placebo
Sponsor: IMPAX Laboratories, Inc.
Recruiting
CLINICALTRIALS.GOV IDENTIFIER:
NCT03670953
FIRST POSTED:
Fri, 14 Sep 2018 12:00:00 EDT
LAST UPDATE POSTED:
05/16/19 07:19AM
STUDY LINK / URL:
https://clinicaltrials.gov/ct2/show/NCT03670953?recrs=abdef&type=Intr&cond=Parkinson+Disease&phase=0124&lupd_s=05%2F02%2F2019&lupd_d=14&sort=nwst
